Plasma asprosin, CCDC80 and ANGPTL4 levels are associated with metabolic and cardiovascular risk in patients with inflammatory bowel disease

. 2021 Apr 30 ; 70 (2) : 203-211. [epub] 20210308

Jazyk angličtina Země Česko Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid33676388

Asprosin, coiled-coil domain-containing 80(CCDC80) and angiopoietin-like4(ANGPTL4) are newly discovered adipocytokine that affects glucose tolerance, insulin resistance and cardiovascular diseases. The goal of this study was to investigate if a relationship exists among asprosin, CCDC80 and ANGPTL4 and inflammatory bowel disease (IBD). Fifty subjects with newly diagnosed IBD and fifty healthy individuals were enrolled. Patients were treated with standard therapies for 3 months. Plasma asprosin, CCDC80 and ANGPTL4 levels were measured with enzyme-linked immunosorbent assay. High resolution ultrasound was used to measure brachial artery diameter at rest, after reactive hyperemia (flow-mediated dilation, FMD) and after sublingual glyceryltrinitrate.Compare with healthy individuals, plasma CCDC80,erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) levels and homeostasis modelassessment of insulin resistance (HOMA-IR) were significantly higher (p < 0.05, respectively), whereas plasma asprosin,ANGPTL4 levels and FMD were significantly lower inboth UC and CD patients(p <0.05). Plasma CCDC80 levels were significantly higher in patients with CD (p<0.05), while plasma asprosin and ANGPTL4 levels were lower (p<0.05) as compared with those in patients with UC. Standard therapies increased plasma asprosin, ANGPTL4 levels and FMD in both UC and CD (p<0.05),UC and CD patientswhile decreased plasma CCDC80, ESR, CRP levels and HOMA-IR (p<0.05). The changes in HOMA-IR and FMD were correlated with the changes in plasma asprosin, CCDC80 and ANGPTL4 levels over the study period (p<0.05). Plasma asprosin, CCDC80 and ANGPTL4 levels may be applied as a significant marker for early stage of insulin resistance and atherosclerosis in IBD, especially of CD.

Zobrazit více v PubMed

BERRIDGE MJ. Vitamin D deficiency and diabetes. Biochem J. 2017;474:1321–1332. doi: 10.1042/BCJ20170042. PubMed DOI

CELEMAJER DS, SORENSEN KE, GOOCH VM, SPIEGELHALTER DJ, MILLER OI, SULLIVAN ID, LIOYD JK, DEANFIELD JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–1115. doi: 10.1016/0140-6736(92)93147-F. PubMed DOI

CIBOR D, DOMAGALA-RODACKA R, RODACKI T, JURCZYSZYN A, MACH T, OWCZAREK D. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol. 2016;22:1067–1077. doi: 10.3748/wjg.v22.i3.1067. PubMed DOI PMC

de LIMA AO, KOLTES JE, DINIZ WJS, De OLIVEIRA PSN, CESAR ASM, TIZIOTO PC, AFONSO J, De SOUZA MM, PETRINI J, ROCHA MIP, CARDOSO TF, NETO AZ, COUTINHO LL, MOURÃO GB, REGITANO LCA. Potential biomarkers for feed efficiency-related traits in nelore cattle identified by co-expression network and integrative genomics analyses. Front Genet. 2020;11:189. doi: 10.3389/fgene.2020.00189. PubMed DOI PMC

DUO G, QIANG Z, LING-YAN C, XIAO-HUA Y, GANG W, JIN Z, XI-LONG Z, DA-WEI Z, WEI-DONG Y, CHAO-KE T. Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 Phosphorylation and TET2 Expression. Eur J Pharmacol. 2019;843:177–189. doi: 10.1016/j.ejphar.2018.11.009. PubMed DOI

GEORGIADI A, LICHTENSTEIN L, DEGENHARDT T, BOEKSCHOTEN MV, Van BILSEN M, DESVERGNE B, MULLER M, KERSTEN S. Induction of cardiac angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ Res. 2010;106:1712–1721. doi: 10.1161/CIRCRESAHA.110.217380. PubMed DOI

GOYETTE P, LABBE C, TRINH TT, XAVIER RJ, RIOUX JD. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med. 2007;39:177–199. doi: 10.1080/07853890701197615. PubMed DOI

HAN CC, JEREMY SOON KC, CHI QG, NATALIA VG, BAIWEN L, XIAOLING W, SELIN F, MARCUS THIEN CW, CLEO C, SANDER K, NGUAN ST. Angiopoietin-like 4 stimulates STAT3-mediated iNOS xpression and enhances angiogenesis to accelerate wound healing in diabetic mice. Mol Ther. 2014;22:1593–1604. doi: 10.1038/mt.2014.102. PubMed DOI PMC

HAO-HUA W, MIN L, GUANG-DA X. Serum HMGB1 Levels and its association with endothelial dysfunction in patients with polycystic ovary syndrome. Physiol Res. 2018;67:911–919. doi: 10.33549/physiolres.933831. PubMed DOI

JEHLICKA P, HUML M, SCHWARZ J, TREFIL L, KOBR J, SYKORA J. Reactive hyperaemia index as a marker of endothelial dysfunction in children with Crohn’s disease is significantly lower than healthy controls. Acta Paediatr. 2014;103:e55–60. doi: 10.1111/apa.12467. PubMed DOI

KORKMAZ H, SAHIN F, IPEKCI SH, TEMEL T, KEBAPCILAR L. Increased pulse wave velocity and relationship with inflammation, insulin, and insulin resistance in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2014;26:725–732. doi: 10.1097/MEG.0000000000000104. PubMed DOI

KRUIDENIER L, KUIPER I, Van DUIJIN W, MARKLUND SL, Van HOGEZAND RA, LAMERS CB, VERSPAGET HW. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J Pathol. 2003;201:7–16. doi: 10.1002/path.1407. PubMed DOI

MAGRO F, SOARES JB, FEMANDES D. Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World Journal of Gastroenterology. 2014;20:4857–4872. doi: 10.3748/wjg.v20.i17.4857. PubMed DOI PMC

MATULEWICZ N, KARCZEWSKA-KUPCZEWSKA M. Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online) 2016;70:1245–1258. PubMed

McCULLOCH LJ, BRAMWELL LR, KNIGHT B, KOS K. Circulating and tissue specific transcription of angiopoietin-like protein 4 in human Type 2 diabetes. Metabolism. 2020;106:154192. doi: 10.1016/j.metabol.2020.154192. PubMed DOI

MIN W, CHUNYAN Y, LING W, YUSHENG L, HONGGANG L, MIN L, XIAOQING Y, YANFENG X. Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity. Ann Nutr Metab. 2019;5:205–212. doi: 10.1159/000503808. PubMed DOI

MORHARDT TL, WINTER HS. Measurement of microvascular function in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2019;68:662–668. doi: 10.1097/MPG.0000000000002252. PubMed DOI

OSORIO-CONLES O, GUITART M, MORENO-NAVARRETE JM, EXCOTE X, DURAN X, FEMANDEZ-REAL JM, GOMEZ-FOIX AM, FEMANDEZ-VELEDO S, VENDRELL J. Adipose tissue and serum CCDC80 in obesity and its association with related metabolic disease. Mol Med. 2017;23:225–234. doi: 10.2119/molmed.2017.00067. PubMed DOI PMC

ONYANGO AN. Cellular stresses and stress responses in the pathogenesis of insulin resistance. Oxid Med Cell Longev. 2018;2018:4321714. doi: 10.1155/2018/4321714. PubMed DOI PMC

SHA C, XIONG W, CHEN-MING Q, JUAN-NI H, XIAO-YU W, CHAO-XUE X, MING-YANG T, RUI Z, HAI-FENG P. Study of the role and mechanism of asprosin/spartin pathway in cardiac microvascular endothelial injury induced by diabete mellitus. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019;50:827–834. PubMed

SHOTA S, YUHEI N, HIROFUMI S, ERQUAN Z, SHIKO O, SOICHIRO M, YOSHIFUMI A, MIZUKI Y, KOKI K, REIKO K, YOSHIHIDE M, KAZUO M, TOSHIO T. Comparative transcriptome analysis identifies ccdc80 as a novel gene associated with pulmonary arterial hypertension. Front Pharmacol. 2016;7:142. doi: 10.3389/fphar.2016.00142. PubMed DOI PMC

NG SC, SHI HY, HAMIDI N, UNDERWOOD FE, TANG W, BENCHIMOL EI, PANACCIONE R, GHOSH S, WU JCY, CHAN FKL, SUNG JJY, KAPLAN GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–2778. PubMed

SEYED MP, REZA JE, SEYED MH, ALI MOTTAGHI M, ANAHITA G, MARYAM G, MOHADESE AN, MAJID K, MAJID GM, GORDON AF, SEYED MRP, AMIR A. Vitamin D in inflammatory bowel disease: From biology to clinical implications. Complement Ther Med. 2019;47:102189. PubMed

ZHENGBIN Z, YANZHEN T, LIWEN Z, BING Z, PAN F, ERHE G, CHENNIAN X, XIAOMING W, WEI Y, YANG S. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 Pathway. Life Sci. 2019;231:116554. doi: 10.1016/j.lfs.2019.116554. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...